Surmodics
SRDX
SRDX was delisted on the 18th of November, 2025.
110 hedge funds and large institutions have $249M invested in Surmodics in 2014 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 4 closing their positions.
495% more call options, than puts
Call options by funds: $339K | Put options by funds: $57K
0% more funds holding
Funds holding: 110 → 110 (0)
0% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 4
4% less capital invested
Capital invested by funds: $260M → $249M (-$10.1M)
11% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 45
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$3.55M |
| 2 |
GI
GAMCO Investors
Greenwich,
Connecticut
|
+$2.09M |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
+$1.78M |
| 4 |
TA
Teton Advisors
Rye,
New York
|
+$1.55M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$1.37M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$3.05M |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$1.65M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.08M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$808K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$794K |
SRDX Hedge Fund Activity: Q2 2014 in Review
110 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in Surmodics (SRDX) for Q2 2014, worth a combined $249M — down 3.9% from $260M a quarter earlier.
Fund positioning in SRDX was balanced in Q2 2014: 4 funds opened new positions, 4 closed out, 40 added to existing stakes and 45 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $3.55M. The largest seller was BlackRock Advisors, cutting an estimated $3.05M.
- 110 institutional investors held Surmodics (SRDX) as of Q2 2014, unchanged from Q1 2014.
- Funds reported $249M of Surmodics stock for Q2 2014, down 3.9% quarter-over-quarter.
- 4 funds opened new Surmodics positions in Q2 2014 and 4 closed out, a net change of 0 holders.
- The largest Surmodics buyer in Q2 2014 was Wellington Management Group, an estimated $3.55M added.
- The largest Surmodics seller in Q2 2014 was BlackRock Advisors, an estimated $3.05M sold.
Based on aggregated 13F filings for Q2 2014.